NCT05598658

Brief Summary

The purpose of this study is to determine the effect of remote ischemic conditioning on cerebral hemodynamics in patients after intravenous thrombolysis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 28, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2024

Completed
Last Updated

August 19, 2024

Status Verified

August 1, 2024

Enrollment Period

10 months

First QC Date

October 25, 2022

Last Update Submit

August 15, 2024

Conditions

Keywords

Remote Ischemic ConditioningIntravenous ThrombolysisCerebral HemodynamicsCerebral AutoregulationCerebral Blood Flow Velocity

Outcome Measures

Primary Outcomes (1)

  • Cerebral autoregulation parameter

    Cerebral autoregulation parameters derived from transfer function analysis. Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler. Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Transfer function analysis will be used to derive the autoregulatory parameter.

    1-10 days

Study Arms (2)

RIC group

ACTIVE COMPARATOR

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mm Hg. RIC will be conducted at 6 and 18-24 hours after intravenous thrombolysis.

Procedure: Remote ischemic conditioning

Sham-RIC group

PLACEBO COMPARATOR

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mm Hg. RIC will be conducted at 6 and 18-24 hours after intravenous thrombolysis.

Procedure: Sham remote ischemic conditioning

Interventions

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 200 mm Hg.

RIC group

Sham remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 60 mm Hg.

Sham-RIC group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥ 18 and \< 80 years, both sexes;
  • a clear clinical diagnosis of acute ischemic stroke and treatment with standard rt-PA (0.9 mg/kg) IVT within 4.5 h of stroke onset;
  • pre-onset modified Rankin Scale (mRS) score ≤1;
  • baseline National Institute of Health Stroke Scale (NIHSS) score ≥5 and ≤25;
  • Glasgow Coma Scale score ≥8.

You may not qualify if:

  • having received bridging therapy (IVT plus mechanical thrombectomy);
  • previous history of atrial fibrillation or electrocardiographic evidence of atrial fibrillation;
  • contraindications to RIC treatment or previous RIC treatment or similar treatment;
  • pregnancy or breastfeeding;
  • life expectancy of ≤3 months or inability to complete the study for other reasons;
  • unwillingness to be followed up or poor treatment compliance or participation in other clinical studies;
  • had insufficient bilateral temporal bone windows for insonation of the middle cerebral artery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Hospital of Jilin University

Changchun, Jilin, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associated Dean of First Hospital of Jilin University

Study Record Dates

First Submitted

October 25, 2022

First Posted

October 28, 2022

Study Start

April 1, 2023

Primary Completion

January 12, 2024

Study Completion

April 12, 2024

Last Updated

August 19, 2024

Record last verified: 2024-08

Locations